Search Results - Barry E. Storer

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease by Yoshihiro Inamoto, Paul J. Martin, Barry E. Storer, Marco Mielcarek, Rainer F. Storb, Paul A. Carpenter

    Published in Haematologica (2014-02-01)
    Get full text
    Article


  2. 2

    Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes by Janghee Woo, Nicholas P. Howard, Barry E. Storer, Min Fang, Cecilia C. Yeung, Bart L. Scott, H. Joachim Deeg

    Published in Haematologica (2017-06-01)
    Get full text
    Article


  3. 3

    Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect by Enrico Maffini, Larry D. Anderson, Brenda M. Sandmaier, Damian J. Green, Barry E. Storer, Dietger Niederwieser, Richard T. Maziarz, David G. Maloney, Rainer Storb

    Published in Haematologica (2018-06-01)
    Get full text
    Article


  4. 4

    Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial by Marco Mielcarek, Terrence Furlong, Barry E. Storer, Margaret L. Green, George B. McDonald, Paul A. Carpenter, Mary E.D. Flowers, Rainer Storb, Michael Boeckh, Paul J. Martin

    Published in Haematologica (2015-06-01)
    Get full text
    Article


  5. 5

    Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia by Janghee Woo, Dae Ro Choi, Barry E. Storer, Cecilia Yeung, Anna B. Halpern, Rachel B. Salit, Mohamed L. Sorror, David W. Woolston, Tim Monahan, Bart L. Scott, H. Joachim Deeg

    Published in Haematologica (2020-03-01)
    Get full text
    Article


  6. 6

    Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferativ... by Federico Monaco, Bart L. Scott, Thomas R. Chauncey, Finn B. Petersen, Barry E. Storer, Frederic Baron, Mary E. Flowers, H. Joachim Deeg, David G. Maloney, Rainer Storb, Brenda M. Sandmaier

    Published in Haematologica (2019-06-01)
    Get full text
    Article


  7. 7

    Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma by Damian J. Green, David G. Maloney, Barry E. Storer, Brenda M. Sandmaier, Leona A. Holmberg, Pamela S. Becker, Min Fang, Paul J. Martin, George E. Georges, Michelle E. Bouvier, Rainer Storb, Marco Mielcarek

    Published in Blood Advances (2017-11-01)
    Get full text
    Article


  8. 8

    Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation by Giancarlo Fatobene, Barry E. Storer, Rachel B. Salit, Stephanie J. Lee, Paul J. Martin, Guang-Shing Cheng, Paul A. Carpenter, Gansuvd Balgansuren, Effie W. Petersdorf, Colleen Delaney, Brenda M. Sandmaier, Filippo Milano, Mary E. Flowers

    Published in Haematologica (2019-04-01)
    Get full text
    Article


  9. 9

    Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease by Yoshihiro Inamoto, Paul J. Martin, Barry E. Storer, Jeanne Palmer, Daniel J. Weisdorf, Joseph Pidala, Mary E. D. Flowers, Mukta Arora, Madan Jagasia, Sally Arai, Xiaoyu Chai, Steven Z. Pavletic, Georgia B. Vogelsang, Stephanie J. Lee

    Published in Haematologica (2014-10-01)
    Get full text
    Article


  10. 10

    Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma by Enrico Maffini, Barry E. Storer, Brenda M. Sandmaier, Benedetto Bruno, Firoozeh Sahebi, Judith A. Shizuru, Thomas R. Chauncey, Parameswaran Hari, Thoralf Lange, Michael A. Pulsipher, Peter A. McSweeney, Leona Holmberg, Pamela S. Becker, Damian J. Green, Marco Mielcarek, David G. Maloney, Rainer Storb

    Published in Haematologica (2019-02-01)
    Get full text
    Article


  11. 11

    A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation by Brian Kornblit, David G. Maloney, Barry E. Storer, Michael B. Maris, Lars Vindeløv, Parameswaran Hari, Amelia A. Langston, Michael A. Pulsipher, Wolfgang A. Bethge, Thomas R. Chauncey, Thoralf Lange, Finn B. Petersen, Kai Hübel, Ann E. Woolfrey, Mary E.D. Flowers, Rainer Storb, Brenda M. Sandmaier

    Published in Haematologica (2014-10-01)
    Get full text
    Article


  12. 12

    Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades by Jason P. Cooper, Barry E. Storer, Noa Granot, Boglark Gyurkocza, Mohamed L. Sorror, Thomas R. Chauncey, Judith Shizuru, Georg-Nikolaus Franke, Michael B. Maris, Michael Boyer, Benedetto Bruno, Firoozeh Sahebi, Amelia A. Langston, Parameswaran Hari, Edward D. Agura, Søren Lykke Petersen, Richard T. Maziarz, Wolfgang Bethge, Julie Asch, Jonathan A. Gutman, Gitte Olesen, Andrew M. Yeager, Kai Hübel, William J. Hogan, David G. Maloney, Marco Mielcarek, Paul J. Martin, Mary E.D. Flowers, George E. Georges, Ann E. Woolfrey, H. Joachim Deeg, Bart L. Scott, George B. McDonald, Rainer Storb, Brenda M. Sandmaier

    Published in Haematologica (2020-06-01)
    Get full text
    Article


Search Tools: